Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Name: Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
Published: 2014
License: Public Domain

Takeda · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

antibodies antigens drug-therapy immunotherapy lymphoma monoclonal

lymphoma, anaplastic large-cell, relapsed, refractory, antigens, cd30, antibody-drug conjugate, antibodies, monoclonal, lymphoma, non-hodgkin, lymphoma, large-cell, anaplastic, monomethyl auristatin e, drug therapy, immunotherapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 846912
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.